SEC Form 4 Reporting Owner · CIK 0002051419

Birgit C Schultes

EVP at Intellia Therapeutics Inc

Bought (12 mo) —
Sold (12 mo) −$78.4K
Form 4 Filings 4
Companies 1
Filing Activity 2026-03-03 first filed 2025-03-04

Trading record

Open-market buys — 0 filings
Open-market sales −$78.9K 2 filings
Sales under a 10b5-1 plan 0% 0 of 2 sale filings

Companies

Open-market shares bought and sold at each company, and the holding after the latest filing
CompanyRoleFilingsBoughtSoldNetHolding after latest filing
NTLAIntellia Therapeutics Insider tradingEVP4—8,539−8,539137,733 2026-03-03

Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.

Insider Trading History

Company Type Value Filed View filing
NTLA Intellia Therapeutics Inc Award — 2026-03-03
NTLA Intellia Therapeutics Inc Sell -$78,359 2026-01-07
NTLA Intellia Therapeutics Inc Sell -$538 2025-10-03
NTLA Intellia Therapeutics Inc Award — 2025-03-04